Clinical Pathway Implementation in ACS STEMI Patients

Wiedya Kristianti Angeline(1), Martina Martina(2), Ermi Girsang(3*), Ali Napiah Nasution(4)
(1) Department of Hospital Management, Faculty of Medicine, Universitas Prima Indonesia
(2) Department of Hospital Management, Faculty of Medicine, Universitas Prima Indonesia
(3) Department of Public Health, Faculty of Medicine, Universitas Prima Indonesia
(4) Department of Public Health, Faculty of Medicine, Universitas Prima Indonesia
(*) Corresponding Author
DOI : 10.30604/jika.v7i3.1229

Abstract

Delay in handling patients with Acute ST-elevation myocardial infarction (STEMI) is the cause of high mortality and the incidence of MACE (Major Adverse Cardiac Event), so efforts are needed to reduce it by handling patients with Acute Coronary Syndrome (ACS) with the implementation of clinical pathways. This study evaluates the application of clinical pathways for ACS STEMI patients based on content and quality and evaluates the effectiveness of clinical pathways based on length of stay, total costs, and outcomes between ACS STEMI patients with clinical pathways and non-clinical pathways. This research uses mixed methods with an exploratory sequential approach. Evaluation of clinical pathways for ACS STEMI patients with a qualitative approach through in-depth interviews using the Integrated Care Pathway Appraisal Tool (ICPAT) questionnaire. Furthermore, a comparative approach is used to determine the effectiveness of clinical pathways based on length of stay, total costs and outcomes (outcomes) between ACS STEMI patients who have and do not have a clinical pathway. The study was conducted from November 2021 to April 2022 at the Cardiology Section of Murni Teguh Hospital, Medan. The results show that the implementation process is of good quality, but the content still needs to be improved. From the test results with the Mann-Whitney U Test, it can be seen that there is an effect of using the application of clinical pathways on length of stay, total costs and outcomes in ACS STEMI patients. It is suggested to the hospital management to determine a strategy to increase the compliance of doctors and nurses to the clinical pathway.

 

Abstrak: Keterlambatan penanganan pasien Acute ST-elevation myocardial infarction (STEMI) menjadi penyebab tingginya mortalitas dan kejadian MACE (Major Adverse Cardiac Event), maka diperlukan upaya dalam menguranginya melalui penanganan pasien Acute Coronary Syndrome (ACS) dengan diberlakukannya clinical pathway. Penelitian ini bertujuan mengevaluasi penerapan clinical pathway pasien ACS STEMI berdasarkan konten dan kualitas serta mengevaluasi efektivitas clinical pathway berdasarkan lama rawat, biaya total dan hasil antara pasien ACS STEMI dengan clinical pathway dan non clinical pathway. Penelitian ini menggunakan mix methods dengan pendekatan exploratory sequential. Evaluasi clinical pathway pasien ACS STEMI dengan pendekatan kualitatif melalui wawancara mendalam menggunakan kuesioner Integrated Care Pathway Appraisal Tool (ICPAT). Selanjutnya pendekatan komparatif digunakan untuk mengetahui efektivitas clinical pathway berdasarkan lama rawat, biaya total dan hasil (outcomes) antara pasien ACS STEMI yang memiliki dan tidak memiliki clinical pathway. Studi dilakukan selama bulan November 2021 hingga April 2022 di Bagian Kardiologi Rumah Sakit Murni Teguh Medan. Hasil penelitian menunjukkan proses implementasi yang dilakukan sudah baik untuk mutu, namun konten masih perlu ditingkatkan. Dari hasil uji dengan Mann Whitney U Test terlihat bahwa ada pengaruh penggunaan penerapan clinical pathway terhadap lama rawat, biaya total dan hasil pada pasien ACS STEMI. Disarankan pada pihak manajemen rumah sakit untuk menentukan strategi dalam meningkatkan kepatuhan dokter dan perawat terhadap clinical pathway.

Keywords


clinical pathway; ACS STEMI; length of stay; total cost; outcomes

References


Arikunto, S. (2014), Prosedur Penelitian: Suatu Pendekatan Praktik, Rineka Cipta, Jakarta.

Armiyanti, Dharma, S. and Wahyudi, W. (2021), “Pengaruh Penerapan Clinical Pathway Diabetes Melitus Tipe 2 Terhadap Lama Hari Rawat di RSUD Sungai Dareh”, Jurnal Kesehatan Medika Saintika, Vol. 12 No. 1, pp. 114–122.

Astuti, Y.D., Dewi, A. and Arini, M. (2017), “Evaluasi Implementasi Clinical Pathway Sectio Caesarea di RSUD Panembahan Senopati Bantul”, Jurnal Medicoeticolegal Dan Manajemen Rumah Sakit, Vol. 6 No. 2, pp. 97–111.

Bjerkan, J., Valderaune, V. and Olsen, R.M. (2021), “Patient Safety Through Nursing Documentation: Barriers Identified by Healthcare Professionals and Students ”, Frontiers in Computer Science , available at: https://www.frontiersin.org/article/10.3389/fcomp.2021.624555.

Bjurling-Sjöberg, P., Wadensten, B., Pöder, U., Nordgren, L. and Jansson, I. (2015), “Factors affecting the implementation process of clinical pathways: a mixed method study within the context of Swedish intensive care”, Journal of Evaluation in Clinical Practice, John Wiley & Sons, Ltd, Vol. 21 No. 2, pp. 255–261.

Candradewi, S.F., Perwitasari, D.A. and Nabilah, N. (2021), “Analisis Biaya dan Luaran Klinis Sindrom Koroner Akut Berbasis Clinical Pathway”, Jurnal Manajemen Dan Pelayanan Farmasi, Vol. 11 No. 2, p. 91.

Chandrashekhar, Y., Alexander, T., Mullasari, A., Kumbhani, D.J., Alam, S., Alexanderson, E., Bachani, D., et al. (2020), “Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries”, Circulation, American Heart Association, Vol. 141 No. 24, pp. 2004–2025.

Creswell, J.W. (2014), Research Design: Qualitative, Quantitative, and Mixed Methods Approaches, 4th ed., SAGE Publications, California.

Eguzo, K.N., Akpanudo, U., Oluoha, C., Ismaila, N., Jacob, A., Nnah, K., Tumba, N., et al. (2021), “Enhancing Nigerian Healthcare Providers Competence in Breast Cancer Clinical Pathway Development using Blended Learning Approach”, Asian Pacific Journal of Cancer Care, Vol. 6 No. 3, pp. 271–276.

Esposito, P. and Dal Canton, A. (2014), “Clinical audit, a valuable tool to improve quality of care: General methodology and applications in nephrology”, World Journal of Nephrology, Baishideng Publishing Group Inc, Vol. 3 No. 4, pp. 249–255.

Fadilah, N.F.N. and Budi, S.C. (2018), “Efektifitas Implementasi Clinical Pathway Terhadap Average Length Of Stay dan Outcomes Pasien DF-DHF Anak di RSUD Kota Yogyakarta”, Jurnal Kesehatan Vokasional, Vol. 2 No. 2, p. 175.

Hadira, Syahrul, S. and Rachmawaty, R. (2020), “Efektivitas Penerapan Integrated Clinical Pathway (ICP) Terkait Manajemen Risiko Terhadap Kualitas Pelayanan di Rumah Sakit: Literatur Review”, Jurnal Keperawatan Muhammadiyah Edisi Khusus, pp. 97–105.

Helzainka, A.A. (2021), “Challenges in the Implementation of Clinical Pathway in Indonesia: A Systematic Review”, Cermin Dunia Kedokteran, Vol. 48 No. 7, pp. 430–434.

Huang, D., Song, X., Tian, J., Cui, Q. and Yang, K.-H. (2015), “Effects of clinical pathways in stroke management: A meta-analysis”, Neurology Asia, Vol. 20, pp. 335–342.

Institute for Health Metrics and Evaluation. (2018), “Findings from the Global Burden of Disease Study 2017”, Seattle, available at: http://www.healthdata.org/sites/default/files/files/policy_report/2019/G BD_2017_Booklet.pdf [20 Mei 2019.

Iroth, J.S., Ahmad, R.A. and Pinzon, R. (2017), “Dampak Penerapan Clinical Pathway Terhadap Biaya Perawatan Pasien Stroke Iskemik Akut di RS Bethesda Yogyakarta”, Berkala Ilmiah Kedokteran Duta Wacana, Vol. 2 No. 1, p. 267.

James, S. and Bueno, H. (2018), “Epidemiology of acute coronary syndromes”, Oxford University Press, Oxford, UK, available at:https://doi.org/10.1093/med/9780198784906.003.0305.

Kementerian Kesehatan. (2018), Riset Kesehatan Dasar 2018 (2018 Basic Health Research), Jakarta.

Knai, C., Hawkesworth, S., Pannella, M., Sermeus, W., McKee, M., Cluzeau, F., Van Zelm, R., et al. (2013), “International experiences in the use of care pathways”, Journal of Care Services Management, Taylor & Francis, Vol. 7 No. 4, pp. 128–135.

Lawal, A.K., Rotter, T., Kinsman, L., Machotta, A., Ronellenfitsch, U., Scott, S.D., Goodridge, D., et al. (2016), “What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review”, BMC Medicine, Vol. 14 No. 1, p. 35.

Longmore, M. (2014), Oxford Handbook of Clinical Medicine (Oxford Medical Handbooks), 9th ed., Oxford University Press.

Mater, W. and Ibrahim, R. (2014), “Delivering Quality Healthcare Services using Clinical Pathways”, International Journal of Computer Applications, Vol. 95 No. 1, pp. 5–8.

Rehman, S., Li, X., Wang, C., Ikram, M., Rehman, E. and Liu, M. (2019), “Quality of Care for Patients with Acute Myocardial Infarction (AMI) in Pakistan: A Retrospective Study”, International Journal of Environmental Research and Public Health , available at:https://doi.org/10.3390/ijerph16203890.

Rosalina, I.S., Mansur, M., Syamsul Hidayat, M.K. and Widyaningrum, K. (2018), “Evaluating Clinical Pathway Typhoid Fever Monitoring at ABC Hospital Malang”, Jurnal Medicoeticolegal Dan Manajemen Rumah Sakit, Vol. 7 No. 1, pp. 43–51.

Rotter, T., de Jong, R.B., Lacko, S.E., Ronellenfitsch, U. and Kinsman, L. (2019), “Clinical pathways as a quality strategy”, Improving Healthcare Quality in Europe: Characteristics, Effectiveness and Implementation of Different Strategies, European Observatory on Health Systems and Policies, Copenhagen.

Rotter, T., Kinsman, L., James, E., Machotta, A., Willis, J., Snow, P. and Kugler, J. (2011), “The Effects of Clinical Pathways on Professional Practice, Patient Outcomes, Length of Stay, and Hospital Costs: Cochrane Systematic Review and Meta-Analysis”, Evaluation & the Health Professions, SAGE Publications Inc, Vol. 35 No. 1, pp. 3–27.

Schmidt, I., Thor, J., Davidson, T., Nilsson, F. and Carlsson, C. (2018), “The national program on standardized cancer care pathways in Sweden: Observations and findings half way through”, Health Policy, Vol. 122 No. 9, pp. 945–948.

Scholz, K.H., Maier, S.K.G., Maier, L.S., Lengenfelder, B., Jacobshagen, C., Jung, J., Fleischmann, C., et al. (2018), “Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial”, European Heart Journal, Vol. 39 No. 13, pp. 1065–1074.

Trimarchi, L., Caruso, R., Magon, G., Odone, A. and Arrigoni, C. (2021), “Clinical pathways and patient-related outcomes in hospital-based settings: a systematic review and meta-analysis of randomized controlled trials”, Acta Bio-Medica : Atenei Parmensis, Mattioli 1885, Vol. 92 No. 1, pp. e2021093–e2021093.

Urizar, E., Nuño, R., Alvarez, C., Concepción, F., Blay, C. and Quiroga, A. (2018), “Barriers and facilitators for the implementation of Integrated Care Pathways ICPs: a systemic perspective”, International Journal of Integrated Care, Vol. 18 No. s2, p. 131.

Vernon, S.T., Coffey, S., D’Souza, M., Chow, C.K., Kilian, J., Hyun, K., Shaw, J.A., et al. (2019), “ST?Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?”, Journal of the American Heart Association, American Heart Association, Vol. 8 No. 21, p. e013296.

Whittle, C., Dunn, L., McDonald, P. and Luc, K. de. (2008), “Assessing the content and quality of pathways”, Changing Clinical Care, 1st ed., CRC Press, p. 13.

Zègre-Hemsey, J.K., Asafu-Adjei, J., Fernandez, A. and Brice, J. (2019), “Characteristics of Prehospital Electrocardiogram Use in North Carolina Using a Novel Linkage of Emergency Medical Services and Emergency Department Data”, Prehospital Emergency Care, Taylor & Francis, Vol. 23 No. 6, pp. 772–779.


Article Statistic

Abstract view : 13 times
PDF (Bahasa Indonesia) views : 0 times

Dimensions Metrics

How To Cite This :

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Wiedya Kristianti Angeline, Martina Martina, Ermi Girsang, Ali Napiah Nasution

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.